2.09 (7.76%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Neutral
Garp
Strong
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Very Weak
Earnings
Neutral
Dividends
Very Weak
Capital Efficiency
Neutral
Balance Sheet
Very Weak
Website
Capricor Therapeutics, Inc.
Telephone
1.858.727.1755
Address
Suite 150, 10865 Road to the Cure, San Diego, CA 92121
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 4.3 - 40.37
Trade Value (12mth)
US$8,532,474.00
1 week
-6.5%
1 month
-23.83%
YTD
-4.91%
1 year
142.09%
All time high
7750.00
EPS 3 yr Growth
91.20%
EBITDA Margin
0.00%
Operating Cashflow
-$70m
Free Cash Flow Return
-29.70%
ROIC
-44.70%
Interest Coverage
-34.90
Quick Ratio
9.00
Shares Outstanding (Fully Diluted)
57m
HALO Sector
Healthcare
Next Company Report Date
11-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 14 May 26 | |
| 14 May 26 | |
| 13 May 26 | |
| 13 May 26 | |
| 08 May 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.83 | -1.15 | -2.26 | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.83 | -1.15 | -2.26 | | | | ||
Growth | % | | | | | 29.6 | -38.1 | -96.7 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
